Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.


Advances in Treatment of Obstructive Hypertrophic Cardiomyopathy

April 29th 2022

Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.

Expert Perspectives on Managing Polyvascular Disease and Coronary Artery Disease

April 29th 2022

A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.

JAK inhibitors for the Management of Atopic Dermatitis (AD)

April 27th 2022

Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.

Expert Perspectives on Novel Treatment Options for Atherosclerotic Cardiovascular Disease and Hypercholesterolemia

April 25th 2022

Experts in endocrinology and cardiology discuss various guideline and treatments for the management of ASCVD and hypercholesterolemia.

Management Strategies and New Directions in the Treatment of Vitiligo

April 18th 2022

Nada Elbuluk, MD, MSc, FAAD, explores the clinical burden of vitiligo and examines the current and future treatment landscape in this upcoming HCPLive Peer Exchange program.

Atopic Dermatitis: The Patient Journey

April 15th 2022

Raj J. Chovatiya, MD, PhD, shares insight on optimizing treatment for patients with atopic dermatitis and addresses unmet needs in the current treatment landscape in this upcoming HCPLive Cure Connections program.

Improving Access to Alternative Therapies for Treatment Resistant Depression

March 31st 2022

A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.

Advances in the Management of ADHD in Adult Population

March 22nd 2022

Key opinion leaders explore the diagnosis, management, and treatment of attention deficit hyperactivity disorder (ADHD) in the adult population and share key insights on the evolving treatment landscape.

Optimizing Anticoagulation in Vascular Disease Patients: Reimagining the Standard of Care

March 11th 2022

A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.

Management of Type 2 Inflammation in Atopic Dermatitis

March 11th 2022

Expert panelists reflect on the selection and use of recently approved treatments, including interleukin pathway inhibitors, for type 2 inflammation in atopic dermatitis.